ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.

Xiaoqing Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.